Popular Trials
Bone Graft
P-15L Bone Graft for Degenerative Disc Disease
This trial is testing if the P-15L bone graft is as safe and effective as traditional methods for helping bones heal in back surgery patients with degenerative disc disease. It focuses on patients who smoke, are obese, or have diabetes because these conditions can make bone healing harder.
Regenerative Medicine
Umbilical Cord Allograft for Musculoskeletal Pain/Injuries
This trial is testing an amniotic fluid product to see if it can reduce pain and improve function in people with muscle and joint problems. The product uses natural substances found in amniotic fluid to reduce inflammation and possibly help heal tissues. It is aimed at patients who do not respond well to regular pain treatments.
Biological
Placental Tissue Extract Injection for Degenerative Disc Disease
This trial is testing an injection made from human placental tissue to treat patients with degenerative disc disease. The goal is to see if this new treatment can help repair and regenerate damaged discs in the spine, reducing pain and improving function.
Popular Filters
View More Related Trials
Frequently Asked Questions
Introduction to degenerative disc disease
What are the top hospitals conducting degenerative disc disease research?
When it comes to advancing the treatment options for degenerative disc disease, several hospitals are leading the way with their innovative clinical trials. In Carmel, Indiana Spine Group is at the forefront of research in this field, currently conducting four active trials focused on degenerative disc disease. With a total of 12 completed trials since their first recorded study in 2006, they have been dedicated to finding new solutions for patients suffering from this condition. Meanwhile, in Austin, Texas, Austin Neurosurgeons are making significant strides as well. Although they have only recently initiated their journey into degenerative disc disease research with four all-time trials and three ongoing studies since recording their first trial in 2018.
Chicago's Rush University Medical Center has also joined this pursuit with three active clinical trials for degenerative disc disease and an impressive record of 11 completed studies since embarking on this path back in 2007.
The Spine Institute of Louisiana located in Shreveport boasts a long-standing commitment to combating degenerative disc disease with its current three ongoing clinical trials and nineteen previously conducted investigations dating back to their very first trial in 2005.
Finally yet importantly is Orthopaedic Institute of Western Kentucky located at Paducah playing crucial role by being engaged actively into researching treatments against such conditions; focusing on two current open end experiments while holding prestigious fourteen accomplished inquiries ever since beginning it's pioneering investigation specifically addressing such ailments just around few years ago starting from2017 onwards
These hospitals situated across various locations demonstrate passion and dedication towards improving the lives of individuals affected by degenerative disc disease. Through cutting-edge research and state-of-the-art facilities, these medical institutions pave the way for advancements that could potentially revolutionize treatment options for millions worldwide
Which are the best cities for degenerative disc disease clinical trials?
Chicago, Illinois; Royal Oak, Michigan; Austin, Texas; Philadelphia, Pennsylvania; and Tampa, Florida are among the top cities for degenerative disc disease clinical trials. These cities have a significant number of active trials focusing on various treatments such as P-15L Bone Graft, Posterior Cervical Stabilization System (PCSS), VIA Disc NP, Virtuous, Tritanium C Anterior Cervical Cage, OSTEOAMP, Synergy Disc, SB-01 For Injection and Physical Therapy. Individuals seeking to participate in innovative research for degenerative disc disease can find opportunities in these cities that offer potential advancements in treatment options and improved quality of life.
Which are the top treatments for degenerative disc disease being explored in clinical trials?
Clinical trials are shedding light on potential breakthroughs in the treatment of degenerative disc disease. Among the top contenders is VIA Disc NP, a promising therapy currently being explored in two active trials dedicated to this condition. With its first listing in 2021, it stands as an innovative approach that holds great promise for patients suffering from degenerative disc disease.
What are the most recent clinical trials for degenerative disc disease?
Exciting advancements in the field of degenerative disc disease have emerged through recent clinical trials, offering potential avenues for treatment. One prominent trial features SB-01 For Injection, a promising intervention currently in Phase 3. This innovative approach holds promise for individuals suffering from degenerative disc disease and has become available as of August 19th, 2022. Additionally, a Phase 4 trial investigated the efficacy of Bupivacaine-Epinephrine Injectable Solution alongside clonidine for this condition—a noteworthy advancement that became available on February 1st, 2022. These studies represent significant strides towards improving the management and care of patients with degenerative disc disease.
What degenerative disc disease clinical trials were recently completed?
Several recent clinical trials have made significant strides in the field of degenerative disc disease research. One notable trial, recently completed, focused on evaluating a potential treatment for this condition. The study involved rigorous investigation and analysis to determine its effectiveness and safety. These breakthroughs are crucial steps forward in advancing our understanding of degenerative disc disease and developing improved treatments for patients suffering from this debilitating condition.